| 英文名称 | 中文名称 | CAS | MF |
|
4-Morpholinecarboximidamide,2,6-dimethyl-
|
|
710275-64-2
|
C7H15N3O
|
|
Piperidine, 3-(1H-imidazol-4-ylmethyl)- (9CI)
|
|
710278-27-6
|
C9H15N3
|
|
4-(2-{[4-Cyclopropyl-5-(4-methyl-1,2,3-thiadiazol-5-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetyl)benzonitrile
|
|
710279-69-9
|
C17H14N6OS2
|
|
9-(2-bromoethyl)-2,7-di-tert-butyl-9H-fluorene
|
9-(2-bromoethyl)-2,7-di-tert-butyl-9H-fluorene
|
710280-54-9
|
C23H29Br
|
|
Benzoic acid, 2-[[[(1R,3S)-3-[[2-(3-Methoxyphenyl)-5-Methyl-4-oxazolyl]Methoxy]cyclohexyl]oxy]Methyl]-6-Methyl-
|
|
710281-33-7
|
C27H31NO6
|
|
3,5-Dichloro-4-methoxy-N-(4-oxazolo[4,5-b]-pyridin-2-yl-phenyl)-benzamide
|
3,5-二氯-4-甲氧基-N-(4-(恶唑并[4,5-B]吡啶-2-基)苯基)苯甲酰胺
|
710284-99-4
|
C20H13Cl2N3O3
|
|
2H-1,3-Thiazine-6-carboxylicacid,3-amino-3,4-dihydro-2-imino-4-oxo-,methylester(9CI)
|
|
710285-99-7
|
C6H7N3O3S
|
|
Benzamide, N-(2-hydroxycyclohexyl)-4-methoxy- (9CI)
|
|
710290-26-9
|
C14H19NO3
|
|
N-(2-bromophenyl)-2,6-difluorobenzamide
|
N-(2-bromophenyl)-2,6-difluorobenzamide
|
710291-06-8
|
C13H8BrF2NO
|
|
Benzamide, 4-methoxy-N-(4-methylcyclohexyl)- (9CI)
|
|
710291-33-1
|
C15H21NO2
|
|
N-[4-(TrifluoroMethyl)phenyl]-3-MethylbenzaMide, 97%
|
N-[4-(三氟甲基)苯基]-3-甲基苯甲酰胺
|
710291-54-6
|
C15H12F3NO
|
|
5-Bromo-2-fluorobenzylidenehydrazine
|
5-Bromo-2-fluorobenzaldehyde hydrazone
|
710292-26-5
|
C7H6BrFN2
|
|
2-[(4-fluorobenzyl)thio]aniline
|
|
710292-49-2
|
C13H12FNS
|
|
1-(3-Chloro-2-methylphenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde
|
1-(3-氯-2-甲基苯基)-2,5-二甲基-1H-吡咯-3-甲醛
|
710296-43-8
|
C14H14ClNO
|
|
1-sec-Butyl-1H-indole-3-carbaldehyde
|
1-(仲丁基)-1H-吲哚-3-甲醛
|
710296-59-6
|
C13H15NO
|
|
5H-Thiazolo[3,2-a]pyrimidine,6,7-dihydro-2,3-dimethyl-(9CI)
|
|
710297-35-1
|
C8H12N2S
|
|
2-(1-Azepanyl)-5-chloroaniline
|
2-(氮杂-1-基)-5-氯苯胺
|
710301-04-5
|
C12H17ClN2
|
|
Edaravone Impurity 10
|
依达拉奉杂质10
|
710307-89-4
|
C10H12N2O2
|
|
1,3,5-Triazine-2,4-diamine,6-(2-propenyl)-(9CI)
|
|
710308-43-3
|
C6H9N5
|
|
Benzamide, 3-fluoro-N-(5-fluoro-2-methylphenyl)- (9CI)
|
|
710309-87-8
|
C14H11F2NO
|
|
Benzamide, 2-fluoro-N-(5-fluoro-2-methylphenyl)- (9CI)
|
2-氟-N-(5-氟-2-甲基苯基)苯甲酰胺
|
710310-20-6
|
C14H11F2NO
|
|
N-(5-Fluoro-2-Methylphenyl)-3-MethylbenzaMide, 97%
|
N-(5-氟-2-甲基苯基)-3-甲基苯甲酰胺
|
710310-21-7
|
C15H14FNO
|
|
3-Chloro-N-(5-fluoro-2-Methylphenyl)benzaMide, 97%
|
3-氯-N-(5-氟-2-甲基苯基)苯甲酰胺
|
710310-22-8
|
C14H11ClFNO
|
|
N-(5-Fluoro-2-Methylphenyl)-4-MethylbenzaMide, 97%
|
N-(5-氟-2-甲基苯基)-4-甲基苯甲酰胺
|
710310-23-9
|
C15H14FNO
|
|
4-bromo-N-(5-fluoro-2-methylphenyl)benzamide
|
4-溴-N-(5-氟-2-甲基苯)苯甲酰胺
|
710310-24-0
|
C14H11BrFNO
|
|
Benzamide, 4-fluoro-N-(5-fluoro-2-methylphenyl)- (9CI)
|
4-氟-N-(5-氟-2-甲基苯)苯甲酰胺
|
710310-25-1
|
C14H11F2NO
|
|
Benzamide, N-(5-fluoro-2-methylphenyl)-4-methoxy- (9CI)
|
N-(5-氟-2-甲基苯基)-4-甲氧基苯甲酰胺
|
710310-26-2
|
C15H14FNO2
|
|
Benzamide, N-cyclopentyl-3-(trifluoromethyl)- (9CI)
|
|
710310-44-4
|
C13H14F3NO
|
|
N-(3-bromophenyl)-3-(trifluoromethyl)benzamide
|
N-(3-溴苯)-3-(三氟甲基)苯甲酰胺
|
710310-54-6
|
C14H9BrF3NO
|
|
Benzamide, 3-fluoro-N-1H-indazol-6-yl- (9CI)
|
|
710310-83-1
|
C14H10FN3O
|
|
Benzoic acid, 4-[(3,5-dimethoxybenzoyl)amino]-2-hydroxy-
|
4-[(3,5-二甲氨苄基)氨基]-2-羟基-苯甲酸
|
710311-03-8
|
C16H15NO6
|
|
Benzamide, N-hydroxy-3,5-dimethoxy- (9CI)
|
|
710311-79-8
|
C9H11NO4
|
|
Letermovir
|
化合物 T26739
|
710312-77-9
|
C34H47N11O9S2
|
|
Hydrazinecarboxylic acid, 2-?(2-?propen-?1-?ylidene)?-?, 1,?1-?dimethylethyl ester
|
|
710314-66-2
|
C8H14N2O2
|
|
N-(4-cyanophenyl)-3-(trifluoromethyl)benzamide
|
N-(4-Cyanophenyl)-3-(trifluoromethyl)benzamide
|
710317-95-6
|
C15H9F3N2O
|
|
2-Chloro-N-(3-Methylbenzyl)benzaMide, 97%
|
2-氯-N-(3-甲基苄基)苯甲酰胺
|
710318-31-3
|
C15H14ClNO
|
|
2-Fluoro-N-(3-Methylbenzyl)benzaMide, 97%
|
2-氟-N-(3-甲基苄基)苯甲酰胺
|
710318-32-4
|
C15H14FNO
|
|
3-Chloro-N-(3-Methylbenzyl)benzaMide, 97%
|
3-氯-N-(3-甲基苄基)苯甲酰胺
|
710318-33-5
|
C15H14ClNO
|
|
4-Methyl-N-(3-Methylbenzyl)benzaMide, 97%
|
4-甲基-N-(3-甲基苄基)苯甲酰胺
|
710318-34-6
|
C16H17NO
|
|
4-BroMo-N-(3-Methylbenzyl)benzaMide, 97%
|
4-溴-N-(3-甲基苄基)苯甲酰胺
|
710318-35-7
|
C15H14BrNO
|
|
4-Fluoro-N-(3-Methylbenzyl)benzaMide, 97%
|
4-氟-N-(3-甲基苄基)苯甲酰胺
|
710318-36-8
|
C15H14FNO
|
|
Cyclopropanecarboxamide, N-(3,4,5-trimethoxyphenyl)- (9CI)
|
|
710319-42-9
|
C13H17NO4
|
|
1,2-Ethanediamine,N-(3-furanylmethylene)-N,N-dimethyl-(9CI)
|
|
710321-07-6
|
C9H14N2O
|
|
N-(5-Bromo-pyrazin-2-yl)-2,2-dimethyl-propionamide
|
N-(5-溴吡嗪-2-基)新戊酰胺
|
710322-28-4
|
C9H12BrN3O
|
|
Pyrazinecarboxylic acid, 5-amino-, 1,1-dimethylethyl ester (9CI)
|
|
710322-34-2
|
C9H13N3O2
|
|
(5-CyanoMethyl-pyrazin-2-yl)-carbaMic acid tert-butyl ester
|
|
710322-47-7
|
C11H14N4O2
|
|
Pyrazinecarboxylic acid, 5-formyl-, methyl ester (9CI)
|
PYRAZINECARBOXYLIC ACID, 5-FORMYL-, METHYL ESTER (9CI)
|
710322-57-9
|
C7H6N2O3
|
|
5-(2-Methoxyethoxy)pyrazin-2-amine
|
5-(2-甲氧基乙氧基)吡嗪-2-胺
|
710322-71-7
|
C7H11N3O2
|
|
N-(5-vinylpyrazin-2-yl)pivalamide
|
710322-81-9
|
710322-81-9
|
C11H15N3O
|
|
Pyrazinamine, 5-(2-methyl-1-propenyl)- (9CI)
|
|
710323-06-1
|
C8H11N3
|
|
5-(3-Thienyl)-2-pyrazinamine
|
5-(噻吩-3-基)吡嗪-2-胺
|
710323-21-0
|
C8H7N3S
|
|
Pyrazinamine, 5-(4,5-dihydro-1H-imidazol-2-yl)- (9CI)
|
|
710323-24-3
|
C7H9N5
|
|
GSK-3 Inhibitor IX, Control, MeBIO
|
GSK-3 Inhibitor IX, Control, MeBIO
|
710323-61-8
|
C17H12BrN3O2
|
|
Benzenamine, 4,4'-[[1,1'-biphenyl]-2,2'-diylbis(oxy)]bis[3-(trifluoromethyl)- (9CI)
|
DYPI1056
|
710323-81-2
|
C26H18F6N2O2
|
|
1,3-Dioxolane, 2,2-dimethyl-4-(1-propynyl)-, (4R)- (9CI)
|
|
710324-25-7
|
C8H12O2
|
|
2,3-Pentanedione, 4,5-dihydroxy-, (4S)- (9CI)
|
(4S)-4,5-二羟基-2,3-戊二酮
|
710324-30-4
|
C5H8O4
|
|
6-Quinolinamine, 2-(4-ethyl-1-piperazinyl)-4-methyl-
|
|
710328-02-2
|
C16H22N4
|
|
3-Penten-2-one, 4-hydroxy-3-mercapto- (5CI)
|
|
710328-88-4
|
C5H8O2S
|
|
4-Penten-2-one,4-methyl-1-phenoxy-(5CI)
|
|
710328-89-5
|
C12H14O2
|
|
2-Pentenylamine,5-methoxy-N,N-dimethyl-(5CI)
|
|
710329-00-3
|
C8H17NO
|
|
Benzamide, N-1H-indazol-5-yl-2-methyl- (9CI)
|
|
710329-42-3
|
C15H13N3O
|
|
Benzamide, 2-fluoro-N-1H-indazol-5-yl- (9CI)
|
|
710329-44-5
|
C14H10FN3O
|
|
1-Piperazinecarbothioamide,4-ethyl-N-(2-methyl-2-propenyl)-(9CI)
|
|
710330-15-7
|
C11H21N3S
|
|
Benzamide, N-(2-acetylphenyl)-4-methyl- (9CI)
|
|
710330-32-8
|
C16H15NO2
|
|
N,N′-(2-Methyl-1,3-phenylene)bis[cyclopropanecarboxamide]
|
|
710330-54-4
|
C15H18N2O2
|
|
Cyclopropanecarboxamide, N-(3,5-dimethyltricyclo[3.3.1.13,7]dec-1-yl)- (9CI)
|
|
710333-30-5
|
C16H25NO
|
|
1-Ethyl-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide
|
1-乙基-1-甲基吡咯烷-1-鎓 双(三氟甲基)亚胺盐
|
710336-92-8
|
C9H16F6N2
|
|
2-ethynyl-5-hexylthiophene
|
2-乙炔基-5-己基噻吩
|
710338-92-4
|
C12H16S
|
|
Milnacipran Impurity 13
|
米那普仑杂质13
|
710339-49-4
|
C12H16NO+
|
|
6-Chloro-1-(3-chlorophenyl)-1-oxohexane
|
6-氯-1-(3-氯苯基)己-1-酮
|
710339-81-4
|
C12H14Cl2O
|
|
2-((10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)methyl)-N,N-dimethylaniline
|
|
710340-97-9
|
C24H23N
|
|
N-(4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide
|
n-(4-甲基-3-(4,4,5,5-四甲基-1,3,2-二氧杂硼烷-2-苯基)甲磺酰胺
|
710348-21-3
|
C14H22BNO4S
|
|
3-(Ethylsulfonamido)phenylboronic acid
|
3-(ETHYLSULFONAMIDO)PHENYLBORONIC ACID
|
710348-41-7
|
C8H12BNO4S
|
|
2-oxo-2,3-dihydrobenzooxazole-5-boronic acid
|
2-oxo-2,3-dihydrobenzooxazole-5-boronic acid
|
710348-42-8
|
C7H6BNO4
|
|
4-(2-(piperidin-1-yl)ethoxy)phenylboronic acid
|
4-(2-(哌啶-1-基)乙氧基)苯基硼酸
|
710348-58-6
|
C13H20BNO3
|
|
3-(Methylthio)phenylboronic acid pinacolate
|
3-METHYLTHIOPHENYLBORONIC ACID, PINACOL ESTER
|
710348-63-3
|
C13H19BO2S
|
|
2-Oxo-2,3-dihydro-1H-benzoimidazole-5-boronic acid, pinacol ester
|
2-氧代-2,3-二氢-1H-苯并咪唑-5-硼酸频那醇酯
|
710348-69-9
|
C13H17BN2O3
|
|
Methyl 2-amino-5-(2-phenylethyl)-1,3-thiazole-4-carboxylate
|
|
710348-76-8
|
C13H14N2O2S
|
|
8-Fluoro-10,11-dihydro-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one
|
8-氟-10,11-二氢-苯并[4,5]环庚烷并[1,2-B]吡啶-5-酮
|
710348-89-3
|
C14H10FNO
|
|
3-Fluoro-5-nitrobenzeneboronic acid pinacol ester, 96%
|
3-氟-5-硝基苯硼酸频哪醇酯
|
710348-94-0
|
C12H15BFNO4
|
|
3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenamine
|
3-氟-5-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苯胺
|
710348-95-1
|
C12H17BFNO2
|
|
(E)-11-BroMoMethylene-3,8-difluoro-6,11-dihydro-dibenzo[b,e]oxepine
|
|
710349-01-2
|
C15H9BrF2O
|
|
4,5-Dihydro-1H-pyrido[3,4-b][1,4]diazepin-2(3H)-one
|
|
710349-41-0
|
C8H9N3O
|
|
4-Piperidinecarbonitrile,4-amino-1-ethyl-(9CI)
|
4-Piperidinecarbonitrile,4-amino-1-ethyl-(9CI)
|
710350-60-0
|
C8H15N3
|
|
8-(2,2,2-trifluoroethyl)-1,4-dioxa-8-azaspiro[4.5]decane(WXFC0424)
|
8-(2,2,2-trifluoroethyl)-1,4-dioxa-8-azaspiro[4.5]decane(WXFC0424)
|
710350-66-6
|
C9H14F3NO2
|
|
4-Piperidinecarbonitrile,4-amino-1-cyclopropyl-(9CI)
|
|
710350-69-9
|
C9H15N3
|
|
Methyl 4-chloro-3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzoate
|
METHYL 4-CHLORO-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE
|
710350-72-4
|
C14H18BClO4
|
|
3-Bromo-4-fluorophenyl isothiocyanate
|
2-溴-1-氟-4-异氰酸苯酯
|
710351-24-9
|
C7H3BrFNS
|
|
Benzenamine, 4-fluoro-3-(1-methylethyl)- (9CI)
|
4-氟-3-异丙基苯胺
|
710351-86-3
|
C9H12FN
|
|
2''-(5-Ethyl-3,4-diphenyl-pyrazol-1-yl)-biphenyl-3-ol
|
2-(5-乙基-3,4-二苯基-吡唑-1-基)-联苯-3-醇
|
710354-39-5
|
C29H24N2O
|
|
Carbamic acid, [(2R,3S)-2-methyl-4-oxo-3-oxetanyl]-, 1,1-dimethylethyl ester
|
Carbamic acid, [(2R,3S)-2-methyl-4-oxo-3-oxetanyl]-, 1,1-dimethylethyl ester
|
710354-67-9
|
C9H15NO4
|
|
4-Imidazolidinone,1,2-dimethyl-3-(1-methylethyl)-(9CI)
|
|
710355-36-5
|
C8H16N2O
|
|
1H-1,5-Benzodiazepine,2-ethyl-2,3-dihydro-2,3,4,8-tetramethyl-(9CI)
|
|
710355-62-7
|
C15H22N2
|
|
(S)-2-(propylaMino)propan-1-ol
|
|
710654-43-6
|
C6H15NO
|
|
2-Morpholinone,5-methyl-4-propyl-,(5S)-(9CI)
|
|
710654-85-6
|
C8H15NO2
|
|
2-Pyridinamine, 5-[(2R,5S)-5-methyl-4-propyl-2-morpholinyl]-
|
710655-15-5
|
710655-15-5
|
C13H21N3O
|
|
alpha-D-Galactopyranoside, 1-methylethyl 2-amino-2-deoxy- (9CI)
|
|
710936-27-9
|
C9H19NO5
|
|
4-Hydroxy-1,3-diMethylpiperidine-4-carboxylic acid
|
4-羟基-1,3-二甲基哌啶-4-羧酸
|
710939-20-1
|
C8H15NO3
|
|
D-Cysteine, 2-methyl-, ethyl ester (9CI)
|
|
710941-52-9
|
C6H13NO2S
|
|
L-(+)-Ribonic acid
|
L-核糖酸
|
710941-59-6
|
C5H10O6
|